Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 369.6 mln doses of COVID-19 vaccines - CDC

08/30/2021 | 02:55pm EDT

Aug 30 (Reuters) - The United States has administered 369,556,911 doses of COVID-19 vaccines in the country as of Monday morning and distributed 440,026,945 doses, the U.S. Centers for Disease Control and Prevention said.

The doses administered are up from the 368,863,734 vaccine doses the CDC said had gone into arms by Aug. 29.

The agency said 204,742,648 people had received at least one dose while 173,832,202 people were fully vaccinated as of 6:00 a.m. ET on Monday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine.

About 955,000 people have received an additional dose of either Pfizer or Moderna's vaccine since Aug. 13, when the U.S. authorized a third dose of the vaccine for people with compromised immune systems who are likely to have weaker protection from the two-dose regimen. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Aditya Soni)


© Reuters 2021
All news about MODERNA, INC.
04:21pMODERNA : Canada considers what to do with millions of unused COVID-19 vaccine doses
AQ
03:48pMODERNA : U.S. administers nearly 412 mln doses of COVID-19 vaccines - CDC
RE
03:32pMODERNA : COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines ma..
RE
01:01pCVS HEALTH : Pharmacies Start Offering Moderna COVID-19 Booster Shots
MT
12:18pEXPLAINER : Is it time to get a COVID-19 booster? Which one?
AQ
10:54aMODERNA : Deutsche Bank Starts Moderna at Sell with $250 Price Target
MT
10:06aWalgreens Starts Offering Moderna, Johnson & Johnson COVID-19 Booster Shots
MT
08:42aCDC approves Moderna, J&J COVID-19 boosters, mixing and matching doses
AQ
05:17aBB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
05:17aPRESS RELEASE : BB Biotech: Gains realized -2-
DJ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash 2021 13 559 M - -
P/E ratio 2021 10,9x
Yield 2021 -
Capitalization 132 B 132 B -
EV / Sales 2021 5,80x
EV / Sales 2022 5,10x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 326,54 $
Average target price 295,79 $
Spread / Average Target -9,42%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.212.57%137 066
LONZA GROUP AG32.03%60 786
IQVIA HOLDINGS INC.42.23%48 830
SEAGEN INC.-0.71%31 638
CELLTRION, INC.-38.86%25 233
ALNYLAM PHARMACEUTICALS, INC.57.21%24 284